R Squared Ltd Invests $156,000 in BellRing Brands, Inc. (NYSE:BRBR)

R Squared Ltd acquired a new stake in BellRing Brands, Inc. (NYSE:BRBR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,070 shares of the company’s stock, valued at approximately $156,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Holocene Advisors LP acquired a new stake in shares of BellRing Brands in the third quarter valued at about $69,998,000. Assenagon Asset Management S.A. boosted its holdings in BellRing Brands by 200.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 992,585 shares of the company’s stock valued at $74,781,000 after acquiring an additional 661,774 shares during the last quarter. E. Ohman J or Asset Management AB acquired a new stake in BellRing Brands during the 3rd quarter valued at approximately $30,753,000. Champlain Investment Partners LLC bought a new position in BellRing Brands during the 3rd quarter worth approximately $30,699,000. Finally, Wasatch Advisors LP lifted its position in shares of BellRing Brands by 8.0% in the 3rd quarter. Wasatch Advisors LP now owns 6,701,299 shares of the company’s stock worth $406,903,000 after purchasing an additional 494,669 shares during the period. 94.97% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on BRBR shares. Barclays increased their price objective on shares of BellRing Brands from $74.00 to $79.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. Citigroup lifted their price objective on BellRing Brands from $83.00 to $90.00 and gave the stock a “buy” rating in a research report on Wednesday. Evercore ISI upped their target price on BellRing Brands from $70.00 to $78.00 and gave the company an “outperform” rating in a research report on Wednesday, November 20th. Stifel Nicolaus lifted their target price on BellRing Brands from $67.00 to $81.00 and gave the stock a “buy” rating in a report on Wednesday, November 20th. Finally, DA Davidson restated a “neutral” rating and set a $75.00 price target on shares of BellRing Brands in a report on Tuesday, November 19th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, BellRing Brands presently has a consensus rating of “Moderate Buy” and a consensus price target of $77.13.

BellRing Brands Trading Up 0.1 %

BRBR opened at $78.21 on Thursday. The company has a market cap of $10.07 billion, a price-to-earnings ratio of 41.82, a PEG ratio of 2.57 and a beta of 0.86. The company’s fifty day moving average price is $75.90 and its two-hundred day moving average price is $65.31. BellRing Brands, Inc. has a 1-year low of $48.06 and a 1-year high of $80.06.

BellRing Brands (NYSE:BRBR) last announced its quarterly earnings results on Monday, November 18th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.01. The business had revenue of $555.80 million for the quarter, compared to analysts’ expectations of $545.00 million. BellRing Brands had a net margin of 12.35% and a negative return on equity of 103.89%. The firm’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.41 EPS. As a group, equities analysts forecast that BellRing Brands, Inc. will post 2.16 earnings per share for the current fiscal year.

About BellRing Brands

BellRing Brands, Inc, together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club, food, drug, mass, eCommerce, specialty, and convenience channels.